Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
FLOWER MOUND, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “the Company”) announced today that it has filed a Form 12b-25, Notification of Late...
-
In 2025, muzastotug showed 29% confirmed overall response rate (ORR) among 21 patients with MSS CRC in the 20 mg/kg dose cohorts Median overall survival (OS) for the 10 mg/kg cohorts was 19.4...
-
Austin, TX, USA, April 02, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Online Clothing Rental Market Size, Trends and Insights By Type...
-
Philadelphia, PA, April 01, 2026 (GLOBE NEWSWIRE) -- LA21 announces the five-year anniversary of its Scale Up Your Business Entrepreneurship Training Program, a structured small business development...
-
Austin, United States, April 01, 2026 (GLOBE NEWSWIRE) -- As Per SNS Insider, the global Healthcare Technology Management Market was valued at USD 34.40 billion in 2025 and is projected to reach USD...
-
Washington, D.C., April 01, 2026 (GLOBE NEWSWIRE) -- The New Civil Liberties Alliance has reached a settlement in our The Daily Wire, The Federalist, Texas v. State Dep’t lawsuit against State...
-
Distribution agreement to enhance channel partner expansion across five U.S. states The collaboration is expected to support adoption of advanced 3D imaging within orthopedic practices and surgical...
-
A Los Angeles Superior Court judge rejected secrecy attempts by Sterling Pathology and its owner Dr. Chang Yang to shield alleged COVID-19 phantom tests
-
Austin, TX, USA, March 31, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lactic Acid and Polylactic Acid PLA Market Size, Trends and Insights By Type...
-
MGH collaboration to evaluate TRE-515 in ALS patients, advancing development of a first-in-class therapy targeting inflammation and nucleotide metabolism.